These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 19410441

  • 1. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E, Bauer S, Alberti C, Jonville-Béra AP, Aujard Y, Bensouda-Grimaldi L, Baud O.
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [Abstract] [Full Text] [Related]

  • 2. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL.
    Cochrane Database Syst Rev; 2017 Oct 24; 10(10):CD001146. PubMed ID: 29063585
    [Abstract] [Full Text] [Related]

  • 3. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D.
    Neonatology; 2015 Oct 24; 107(4):358-9. PubMed ID: 26044104
    [Abstract] [Full Text] [Related]

  • 4. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA, Doyle LW.
    Cochrane Database Syst Rev; 2010 Jan 20; (1):CD001146. PubMed ID: 20091516
    [Abstract] [Full Text] [Related]

  • 5. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH, Fayon M, Baud O, Autret-Leca E, Danan M, de Verdelhan A, Castot A.
    Arch Pediatr; 2010 Oct 20; 17(10):1480-7. PubMed ID: 20864322
    [Abstract] [Full Text] [Related]

  • 6. Corticosteroids for the prevention and treatment of bronchopulmonary dysplasia: an overview of systematic reviews.
    van de Loo M, van Kaam A, Offringa M, Doyle LW, Cooper C, Onland W.
    Cochrane Database Syst Rev; 2024 Apr 10; 4(4):CD013271. PubMed ID: 38597338
    [Abstract] [Full Text] [Related]

  • 7. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Doyle LW, Ehrenkranz RA, Halliday HL.
    Cochrane Database Syst Rev; 2014 May 13; (5):CD001146. PubMed ID: 24825456
    [Abstract] [Full Text] [Related]

  • 8. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW, Cheong JL, Ehrenkranz RA, Halliday HL.
    Cochrane Database Syst Rev; 2017 Oct 24; 10(10):CD001145. PubMed ID: 29063594
    [Abstract] [Full Text] [Related]

  • 9. Update on Postnatal Steroids.
    Halliday HL.
    Neonatology; 2017 Oct 24; 111(4):415-422. PubMed ID: 28538237
    [Abstract] [Full Text] [Related]

  • 10. Early (&lt; 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW, Cheong JL, Hay S, Manley BJ, Halliday HL.
    Cochrane Database Syst Rev; 2021 Oct 21; 10(10):CD001146. PubMed ID: 34674229
    [Abstract] [Full Text] [Related]

  • 11. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA, Doyle LW.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD001146. PubMed ID: 19160190
    [Abstract] [Full Text] [Related]

  • 12. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide.
    Halliday HL, Patterson CC, Halahakoon CW, European Multicenter Steroid Study Group.
    Pediatrics; 2001 Feb 21; 107(2):232-40. PubMed ID: 11158452
    [Abstract] [Full Text] [Related]

  • 13. Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
    Onland W, Offringa M, van Kaam A.
    Cochrane Database Syst Rev; 2012 Apr 18; (4):CD002311. PubMed ID: 22513906
    [Abstract] [Full Text] [Related]

  • 14. Update on Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
    Filippone M, Nardo D, Bonadies L, Salvadori S, Baraldi E.
    Am J Perinatol; 2019 Jul 18; 36(S 02):S58-S62. PubMed ID: 31238361
    [Abstract] [Full Text] [Related]

  • 15. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY, Li JC, Liu YL, Zhao XB, Male M, Song DK, Bai Y.
    Curr Med Sci; 2019 Jun 18; 39(3):493-499. PubMed ID: 31209823
    [Abstract] [Full Text] [Related]

  • 16. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL, Ehrenkranz RA.
    Cochrane Database Syst Rev; 2001 Jun 18; (2):CD001145. PubMed ID: 11405975
    [Abstract] [Full Text] [Related]

  • 17. The use of inhaled glucocorticosteroids and recovery from adrenal suppression after systemic steroid use in a VLBW premature infant with BPD: case report and literature discussion.
    Karinski DA, Balkundi D, Rubin LP, Padbury JF.
    Neonatal Netw; 2000 Dec 18; 19(8):27-32. PubMed ID: 11949271
    [Abstract] [Full Text] [Related]

  • 18. The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants.
    Warmerdam LA, van Wezel-Meijler G, de Vries LS, Groenendaal F, Steggerda SJ.
    Neonatology; 2023 Dec 18; 120(5):615-623. PubMed ID: 37379806
    [Abstract] [Full Text] [Related]

  • 19. Neurodevelopment at 24 months corrected age in extremely preterm infants treated with dexamethasone alternatives during the late postnatal period: a cohort study.
    Melan N, Pradat P, Godbert I, Pastor-Diez B, Basson E, Picaud JC.
    Eur J Pediatr; 2024 Feb 18; 183(2):677-687. PubMed ID: 37955745
    [Abstract] [Full Text] [Related]

  • 20. Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.
    Doyle LW.
    Neonatology; 2021 Feb 18; 118(2):244-251. PubMed ID: 33975319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.